Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus
Status:
Completed
Trial end date:
2018-08-16
Target enrollment:
Participant gender:
Summary
This study is a Phase I study to investigate the addition of inhaled Ipratropium bromide to
standard therapy in the treatment of severe asthma attacks in children admitted to the
Pediatric Intensive Care Unit. Half of the subjects will receive inhaled Ipratropium, and
half will receive an inhaled placebo.